Figure 1From: Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study Overview of SIRFLOX study design. Figure footnote: * Bevacizumab, at the investigator’s discretion, but not until cycle 4.Back to article page